Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 369, Issue 25, Pages 2457-2457Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa1206168
Keywords
-
Categories
Ask authors/readers for more resources
To the Editor: The meta-analysis by Shlipak et al. (Sept. 5 issue)(1) shows that a cystatin C-based estimated glomerular filtration rate (eGFR) offers improvements in predicting risks of death and end-stage renal disease across diverse populations. In their editorial, Ingelfinger and Marsden(2) caution that results cannot be applied to Asian and Hispanic patients except by extrapolation. Also, diabetes was underrepresented in the sample of patients with chronic kidney disease; it was present in only 9% of participants. Further, more information is still needed about the use of cystatin C in pregnant women, patients who have undergone renal transplantation, and children. ...
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available